News_

Scientists pave way for diamonds to trace early cancers

12 October 2015
Research published in Nature Communications reveals how nanoscale 'diamonds' can light up early-stage cancers in MRI scans

Physicists at the ARC Centre of Excellence for Engineered Quantum Systems have devised a way to use diamonds to target tumours. The research was published in Nature Communications and led by Professor David Reilly. 

This is a great example of how quantum physics tackles real-world problems—opening the way for us to image and target cancers
Professor David Reilly

Hyperpolerised nanodiamonds

Prof Reilly explains his findings, with animation

Published in Nature Communications, the findings show how a nanoscale, synthetic 'diamond' can light up early-stage cancers in MRI scans.

Physicists from the University of Sydney have devised a way to use diamonds to identify cancerous tumours before they become life threatening.

Their findings, published recently in Nature Communications, reveal how a nano-scale, synthetic version of the precious gem can light up early-stage cancers in non-toxic, non-invasive Magnetic Resonance Imaging (MRI) scans.

Targeting cancers with tailored chemicals is not new but scientists struggle to detect where these chemicals go since, short of a biopsy, there are few ways to see if a treatment has been taken-up by a cancer.

Led by Professor David Reilly from the School of Physics, researchers from the University investigated how nanoscale diamonds could help identify cancers in their earliest stages.

"We knew nano diamonds were of interest for delivering drugs during chemotherapy because they are largely non-toxic and non-reactive," says Professor Reilly.

"We thought we could build on these non-toxic properties realising that diamonds have magnetic characteristics enabling them to act as beacons in MRIs. We effectively turned a pharmaceutical problem into a physics problem."

Professor Reilly's team turned its attention to hyperpolarising nano-diamonds, a process of aligning atoms inside a diamond so they create a signal detectable by an MRI scanner.

"By attaching hyperpolarised diamonds to molecules targeting cancers the technique can allow tracking of the molecules' movement in the body," says Ewa Rej, the paper's lead author.

"This is a great example of how quantum physics research tackles real-world problems, in this case opening the way for us to image and target cancers long before they become life-threatening," says Professor Reilly.

The next stage of the team's work involves working with medical researchers to test the new technology on animals. Also on the horizon is research using scorpion venom to target brain tumours with MRI scanning.

The research documented in the paper Hyperpolarized Nanodiamond with Long Spin Relaxation Times was done by the ARC Centre of Excellence for Engineered Quantum Systems at the University's School of Physics.

Read more on ABC online.

Verity Leatherdale

Manager, Faculty Media and PR
Fax
  • +61 2 9351 3737
Address
  • Level 7 Jane Foss Russell Building G02

Related articles

06 February 2016

Study explains elastin's remarkable movements

New research likens the flexibility of elastin in a blood vessel to the dynamics of a ballet.

14 February 2012

Human 'shock absorbers' discovered

An international team of scientists, led by the University of Sydney, has found the molecular structure in the body which functions as our 'shock absorber'.
29 March 2019

Sydney excels in national research engagement and impact assessment

The University of Sydney has performed strongly in the Australian Research Council's first Engagement and Impact Assessment of research at Australian universities.
29 August 2019

Sydney researchers secure $38 million in NHMRC funding

University of Sydney researchers have excelled in the latest National Health and Medical Research Council (NHMRC) funding round, attracting more than $38 million for our projects extending from Sydney to rural NSW.
16 July 2019

Cannabis treatment counters addiction: first study of its kind

A Sydney-led study published in a JAMA journal provides the first strong evidence that medicinal cannabis could reduce the rate of relapse for users of cannabis - a leading cause of drug treatment episodes in Australia.
06 November 2017

$2.3 million to support industry partnerships for 21 projects

Twenty-one projects have been awarded funding under the University's industry and community engagement seed fund.

12 September 2017

Incredible gift means a cure is in sight

Most of us walk through life never having to think about the fact that we can see clearly. But for many Australians, loss of vision is a real problem - and it can be especially scary when it comes out of the blue.

16 October 2017

4 reasons why food is more important than you think

Access to food is a basic human right, vital for good health and ultimately for life itself. But how often do you wonder where your next meal is coming from, who's growing it, and whether it's actually good for you?

25 July 2018

University of Sydney finalists announced in Eureka Prizes

From maths to medical technology to chemistry for the future - the University celebrates five finalists in the Eureka Prizes, each displaying innovation and leadership in their efforts leading critical advances in science.
16 July 2018

Sydney Analytical launches world-class facility for researchers

The University of Sydney unveils its newest core facility, Sydney Analytical, with capabilities in spectroscopy, x-ray analysis, chemical characterisation, training and access for industry.